Evidence map›Paper›PMID 23771518›Full record

ReviewEnvironmental health perspectives2013

Current perspectives on the use of alternative species in human health and ecological hazard assessments.

Edward J Perkins, Gerald T Ankley, Kevin M Crofton, Natàlia Garcia-Reyero, Carlie A LaLone, Mark S Johnson, Joseph E Tietge, Daniel L Villeneuve

Abstract readReview
In one paragraph

Review in Environmental health perspectives, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Chios Mastic Gum Extract Enhances Antioxidant Defense in Zebrafish.International journal of molecular sciences · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
  12. Use of Zebrafish in Drug Discovery Toxicology.Chemical research in toxicology · 2020
    Review
  13. C3orf70 Is Involved in Neural and Neurobehavioral Development.Pharmaceuticals (Basel, Switzerland) · 2019
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. In vitro to in vivo extrapolation for high throughput prioritization and decision making.Toxicology in vitro : an international journal published in association with BIBRA · 2018
    Review
  20. Tissue-Based Mapping of the Fathead Minnow (Frontiers in endocrinology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Edward J PerkinsUS Army Engineer Research and Development Center, Vicksburg, Mississippi, USA. edward.j.perkins@usace.army.mil
Gerald T Ankley
Kevin M Crofton
Natàlia Garcia-Reyero
Carlie A LaLone
Mark S Johnson
Joseph E Tietge
Daniel L Villeneuve

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional animal toxicity tests can be time and resource intensive, thereby limiting the number of chemicals that can be comprehensively tested for potential hazards to humans and/or to the environment.

objectiveWe compared several types of data to demonstrate how alternative models can be used to inform both human and ecological risk assessment.

methodsWe reviewed and compared data derived from high throughput in vitro assays to fish reproductive tests for seven chemicals. We investigated whether human-focused assays can be predictive of chemical hazards in the environment. We examined how conserved pathways enable the use of nonmammalian models, such as fathead minnow, zebrafish, and Xenopus laevis, to understand modes of action and to screen for chemical risks to humans.

resultsWe examined how dose-dependent responses of zebrafish embryos exposed to flusilazole can be extrapolated, using pathway point of departure data and reverse toxicokinetics, to obtain human oral dose hazard values that are similar to published mammalian chronic toxicity values for the chemical. We also examined how development/safety data for human health can be used to help assess potential risks of pharmaceuticals to nontarget species in the environment. DISCUSSION: Using several examples, we demonstrate that pathway-based analysis of chemical effects provides new opportunities to use alternative models (nonmammalian species, in vitro tests) to support decision making while reducing animal use and associated costs.

conclusionsThese analyses and examples demonstrate how alternative models can be used to reduce cost and animal use while being protective of both human and ecological health.

Indexed as

Models, AnimalAnimalsAnimal Testing AlternativesCyprinidaeDose-Response Relationship, DrugHigh-Throughput Screening AssaysHumansRisk AssessmentSilanesSpecies SpecificityToxicity TestsTriazolesXenopus laevisZebrafishflusilazoleSilanesTriazoles

Identifiers

PMID23771518
PMCPMC3764090

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.